Hyprevention develops STRUTPLASTY®, a technology utilizing PEEK implants and PMMA bone cement to reinforce bones weakened by osteoporosis or cancer. This system is engineered to treat existing fractures and provide preventative support against future skeletal compromise. The company focuses on patient-centric design, integrating in-house research with clinical expertise to deliver effective orthopedic solutions.
Funding
$4.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients with bone conditions such as osteoporosis or cancer face an increased risk of fractures due to weakened bone structure. Existing treatments may not always provide sufficient reinforcement, leaving patients vulnerable to debilitating breaks.
Solution
Hyprevention offers the STRUTPLASTY® Technology, a system designed to reinforce compromised bone. This technology integrates implantable PEEK polymer devices with PMMA bone cement to provide structural support and prevent fractures. The approach focuses on addressing patient needs through a scientifically grounded methodology, combining internal and external expertise to identify clinical challenges and develop optimal product designs.
Target Audience
The primary target audience includes orthopedic surgeons, spine surgeons, and interventional radiologists who treat patients with bone fragility due to osteoporosis or metastatic disease.
Features
- STRUTPLASTY® Technology utilizes implantable PEEK polymer devices for bone reinforcement.
- Devices are combined with PMMA bone cement for enhanced bone anchoring and structural integrity.
- V-STRUT is a percutaneous vertebral augmentation device for thoracic or lumbar spine fractures caused by osteoporosis or tumors.
- V-STRUT is FDA cleared (class II).
- Y-STRUT is a hip implant for internal fixation of the proximal femur in patients at risk of osteoporotic fracture or for impeding pathological fractures.
- Y-STRUT is intended for biomechanical reinforcement of the proximal femur.
- Y-STRUT was granted Breakthrough Device designation by the FDA.
- The technology supports minimally invasive surgical techniques.